Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

BACKGROUND: Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX) and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel (GnP) (nab-PTX) improve the prognosis of patients with metastatic pancreatic cancer. However, no study has compared the efficacy...

詳細記述

保存先:
書誌詳細
出版年:J Gastrointest Oncol
主要な著者: Muranaka, Tetsuhito, Kuwatani, Masaki, Komatsu, Yoshito, Sawada, Kentaro, Nakatsumi, Hiroshi, Kawamoto, Yasuyuki, Yuki, Satoshi, Kubota, Yoshimasa, Kubo, Kimitoshi, Kawahata, Shuhei, Kawakubo, Kazumichi, Kawakami, Hiroshi, Sakamoto, Naoya
フォーマット: Artigo
言語:Inglês
出版事項: AME Publishing Company 2017
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5506289/
https://ncbi.nlm.nih.gov/pubmed/28736643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.02.02
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料